Moximed picks up about $33 mln

Hayward, California-based Moximed, a maker of solutions for patients with knee osteoarthritis, has secured about $33 million in funding. The investors included Vertex Venture Holdings Ltd, New Enterprise Associates, Gilde Healthcare Partners, Morgenthaler Ventures and GBS Venture Partners. In addition to the funding, Dr. Christopher Shen of Vertex, has been added to Moximed’s board of directors.


Socrata nabs $30 mln in Sapphire Ventures-led round

Socrata has received $30 million in Series C funding in a round led by Sapphire Ventures. Other investors were return backers OpenView Venture Partners, Morgenthaler Ventures and Frazier Technology Partners. Socrata is a provider of cloud solutions for open data and data-driven government.


Intuit to buy VC-backed Check for about $360 mln

Intuit has agreed to acquire Check for approximately $360 million. The transaction is expected to close in the fourth fiscal quarter of 2014. Based in Palo Alto, Calif., Check is an app that helps users pay bills. Its backers include Morgenthaler Ventures, Pitango Venture Capital and Menlo Ventures.


Doximity raises $54 mln from DFJ, T Rowe Price, others

Doximity said it closing a $54 million round of Series C funding co-led by Draper Fisher Jurvetson and T. Rowe Price Associates, Inc. Morgan Stanley Investment Management also participated in the round as a new investor. Existing investors Emergence Capital Partners, Morgenthaler Ventures and InterWest Partners also joined the financing. Doximity, an online network for doctors, has more than tripled its user base since its last funding in September 2012 and has one in three U.S. doctors as members, the company said.

Principia Biopharma nabs $50 mln Series B funds

Principia Biopharma has raised $50 million in Series B financing. Sofinnova Ventures led the round with participation from investors that include Morgenthaler Ventures, New Leaf Venture Partners, OrbiMed, SR One and Mission Bay Capital. In addition to the financing, Dr. Srinivas Akkaraju, a general partner at Sofinnova Ventures, has been added to Principia Biopharma’s board of directors. Based in South San Francisco, Principia Biopharma is focused on developing small molecule drugs within the fields of autoimmune disease and oncology.

H.I.G. BioVentures leads Series C round for ForSight VISION5

ForSight VISION5 has closed $15 million in Series C financing. H.I.G. BioVentures led the round with participation from previous backers Morgenthaler Ventures, Versant Ventures, Technology Partners and Delphi Ventures. Concurrent with the funding, Aaron Davidson of H.I.G. BioVentures has been added to ForSight VISION5’s board of directors. Based in Menlo Park, Calif., ForSight VISION5 focuses on developing products that replace eye drops.


Vapotherm bags $24 mln

Vapotherm has raised $24 million in financing. Gilde Healthcare Partners led the round with participation from investors that included Adage Capital Management, 3×5 Special Opportunity Fund, Morgenthaler Ventures, QuestMark Partners and Cross Creek Capital. Based in Exeter, NH, Vapotherm is a maker of advanced respiratory care devices. PRESS RELEASE EXETER, N.H., April 3, 2014 /PRNewswire/ […]

Morgenthaler Ventures announces winners of the DC to VC 2013

Morgenthaler Ventures has announced the winners of DC to VC’s HIT Startup Showcase, a contest that identifies promising health IT startups seeking funding. After eight on-stage presentations in front of venture capitalists, angel investors, government officials and entrepreneurs, the judges selected Amplify Health as the winner of the enterprise solutions category and Kinsa as the winner of the consumer solutions category.

Convo raises $5 mln from Morgenthaler

Cloud-based collaboration service provider Convo has raised $5 million in a Series A funding round from Morgenthaler Ventures. The San Francisco-based company, formerly known as Scyrbe, had previously raised seed funding from Adobe, LMKR and angel investors. As part of the Series A, Morgenthaler Managing Director Rebecca Lynn and Venture Partner Alex Nigg have joined the board. Morgenthaler said that its investment in Convo is the last new IT deal from its ninth fund.

OpenView Venture Partners Leads Socrata B Round

Socrata, a cloud software company has closed an $18 million Series B round of financing led by OpenView Venture Partners, with participation from existing investors Morgenthaler Ventures and Frazier Technology Partners. Scott Maxwell, OpenView’s senior managing director and founder, will join Socrata’s board of directors.

NEA Leads $37M Round in MuleSoft

MuleSoft, which provides enterprises with a cloud-based platform to integrate its mobile and on-premise data and applications, has raised $37 million in new funding. New Enterprise Associates lead the round, with participation from, as well as returning investors Hummer Winblad Venture Partners, Morgenthaler Ventures, Lightspeed Venture Partners, SAP Ventures and Bay Partners. The company has now raised about $81 million in capital since 2006.

Principia Biopharma Inks $12.5M

Principia Biopharma Inc., a biopharmaceutical company focused on immunology, autoimmune diseases, and oncology, has raised $12.5 million. Investors include New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.

Medical Records Manager Practice Fusion Dials Up $34M Round

Practice Fusion, which operates an electronic medical record platform for 150,000 medical providers, has raised a $34 million Series C round of funding led by Artis Ventures. Other investors in the round include Felicis Ventures, Band of Angels, Founders Fund, Morgenthaler Ventures and SV Angel. among other institutional and individual investors. The company says it has now raised $64 million in total funding since it was launched in 2007.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget